OA09.04 Osimertinib with or without SRS for Brain Metastases from EGFRm NSCLC: Pooled Analysis of Two RCTs
| Autor: | Ho, C., Soon, Y.Y., Nichol, A., Robledo, K., Sahgal, A., Pinkham, M., Melosky, B., Huang, Y., Parmar, A., Solomon, B., Tham, I.W.K., Sacher, A., Tey, J.C.S., Menjak, I., Leong, C.N., Shultz, D., Koh, W.Y., Doherty, M., Ang, Y., Low, J., Yong, C., Lim, M.C., Tan, A.P., Lee, C.K., Soo, R., Lefresne, S., Hegi-Johnson, F. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2024 19(10) Supplement:S28-S29 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|